InvestorsHub Logo
Post# of 316810
Next 10
Followers 363
Posts 113918
Boards Moderated 5
Alias Born 12/28/2000

Re: Buckey post# 316171

Thursday, 03/14/2024 7:33:15 AM

Thursday, March 14, 2024 7:33:15 AM

Post# of 316810
Wow, sprb now down 76% at 1.27 - said it would terminate its CAHmelia-203 study, which was evaluating tildacerfont to treat adult classic congenital adrenal hyperplasia And here is the pipeline - looks like a one drug co:
https://sprucebio.com/pipeline/tildacerfont/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.